• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PET/CT 在头颈部鳞癌原发灶不明评估中的临床应用:一项前瞻性临床试验。

Clinical utility of PET/CT in the evaluation of head and neck squamous cell carcinoma with an unknown primary: a prospective clinical trial.

机构信息

Division of Otolaryngology-Head & Neck Surgery, Department of Surgery, University of Calgary, Calgary, Canada.

出版信息

Head Neck. 2011 Jul;33(7):935-40. doi: 10.1002/hed.21566. Epub 2010 Nov 12.

DOI:10.1002/hed.21566
PMID:21674668
Abstract

BACKGROUND

Metastatic head and neck squamous cell carcinoma with an unknown primary is an uncommon but important problem. PET/CT, as an adjunct to diagnosis, is potentially useful but has never been studied in a prospective, single-blinded clinical trial.

METHODS

In all, 20 subjects with cervical metastases from an unknown head and neck primary were enrolled in a prospective clinical trial. A standard protocol was used in both clinic and operating room (OR). Study surgeons were blinded to the PET/CT result upon completion of the standard work-up.

RESULTS

PET/CT increased the detection of a primary site from 25% to 55% (5 vs 11 subjects). This difference was statistically and clinically significant (p = .03, McNemar's test). There was 1 false negative PET/CT scan.

CONCLUSIONS

An unknown primary should be diagnosed only after a complete head and neck examination, flexible endoscopy, and CT or MRI. PET/CT performed prior to panendoscopy will increase the diagnostic yield in the unknown head and neck primary population, leading to more targeted, and less morbid, treatment.

摘要

背景

不明原发灶的转移性头颈部鳞状细胞癌是一种不常见但很重要的问题。PET/CT 作为一种辅助诊断方法具有潜在的作用,但尚未在前瞻性、单盲临床试验中进行研究。

方法

共有 20 例头颈部原发灶不明的颈部转移患者参与了一项前瞻性临床试验。在诊所和手术室(OR)均采用标准方案。研究外科医生在完成标准检查后对 PET/CT 结果进行盲法评估。

结果

PET/CT 将原发灶的检出率从 25%提高到 55%(5 例 vs 11 例)。这一差异具有统计学和临床意义(p =.03,McNemar 检验)。有 1 例 PET/CT 扫描假阴性。

结论

只有在进行全面的头颈部检查、软性内镜检查以及 CT 或 MRI 后,才能诊断不明原发灶。在全内镜检查前进行 PET/CT 检查将提高不明头颈部原发灶人群的诊断率,从而实现更有针对性、更少创伤的治疗。

相似文献

1
Clinical utility of PET/CT in the evaluation of head and neck squamous cell carcinoma with an unknown primary: a prospective clinical trial.PET/CT 在头颈部鳞癌原发灶不明评估中的临床应用:一项前瞻性临床试验。
Head Neck. 2011 Jul;33(7):935-40. doi: 10.1002/hed.21566. Epub 2010 Nov 12.
2
Management of the unknown primary carcinoma: long-term follow-up on a negative PET scan and negative panendoscopy.未知原发性癌的管理:PET扫描阴性和全内镜检查阴性的长期随访
Head Neck. 2008 Jan;30(1):28-34. doi: 10.1002/hed.20654.
3
Role of 18-Fludeoxyglucose positron emission tomography-computed tomography and subsequent panendoscopy in head and neck squamous cell carcinoma of unknown primary.18-氟脱氧葡萄糖正电子发射断层扫描-计算机断层扫描及后续全面内镜检查在原发灶不明的头颈部鳞状细胞癌中的作用
Laryngoscope. 2016 Jun;126(6):1354-8. doi: 10.1002/lary.25783. Epub 2015 Dec 16.
4
Diagnostic evaluation of squamous cell carcinoma metastatic to cervical lymph nodes from an unknown head and neck primary site.对来源于头颈部不明原发灶的鳞状细胞癌转移至颈部淋巴结的诊断评估。
Laryngoscope. 2009 Dec;119(12):2348-54. doi: 10.1002/lary.20638.
5
Utility of panendoscopy for the detection of unknown primary head and neck cancer in patients with a negative PET/CT scan.全内镜检查在PET/CT扫描阴性的患者中检测未知原发头颈癌的效用。
Ear Nose Throat J. 2011 Aug;90(8):E16-20. doi: 10.1177/014556131109000818.
6
Incremental (?) role of positron emission tomography/computed tomography in clinically unknown primary patients with neck metastasis.正电子发射断层扫描/计算机断层扫描在颈部转移瘤临床原发灶不明患者中的增量(?)作用
Indian J Cancer. 2014 Apr-Jun;51(2):142-4. doi: 10.4103/0019-509X.138240.
7
Diagnostic evaluation of squamous cell carcinoma metastatic to cervical lymph nodes from an unknown head and neck primary site.来自不明头颈部原发部位转移至颈部淋巴结的鳞状细胞癌的诊断评估。
Head Neck. 1998 Dec;20(8):739-44. doi: 10.1002/(sici)1097-0347(199812)20:8<739::aid-hed13>3.0.co;2-0.
8
Cervical lymph node metastases of squamous cell carcinoma of unknown origin: the diagnostic value of FDG PET/CT and clinical outcome.原发灶不明的鳞状细胞癌颈部淋巴结转移:FDG PET/CT的诊断价值及临床结局
Eur Arch Otorhinolaryngol. 2017 Feb;274(2):1015-1019. doi: 10.1007/s00405-016-4318-5. Epub 2016 Sep 26.
9
Comparison of whole-body PET/CT, dedicated high-resolution head and neck PET/CT, and contrast-enhanced CT in preoperative staging of clinically M0 squamous cell carcinoma of the head and neck.全身PET/CT、专用高分辨率头颈PET/CT及增强CT在临床M0期头颈部鳞状细胞癌术前分期中的比较
J Nucl Med. 2009 Aug;50(8):1205-13. doi: 10.2967/jnumed.109.062075. Epub 2009 Jul 17.
10
Metastatic squamous cell carcinoma of the gingiva appearing as a solitary branchial cyst carcinoma: diagnostic role of PET/CT.表现为孤立性鳃裂囊肿癌的牙龈转移性鳞状细胞癌:PET/CT的诊断作用
Int J Clin Exp Pathol. 2014 Sep 15;7(10):7059-63. eCollection 2014.

引用本文的文献

1
Head and Neck Cancer of Unknown Primary: A Multicenter Retrospective Cohort study in Northern Thailand, an Endemic Nasopharyngeal Cancer Area.头颈部不明原发癌:泰国北部鼻咽癌高发地区多中心回顾性队列研究。
Asian Pac J Cancer Prev. 2024 Feb 1;25(2):699-708. doi: 10.31557/APJCP.2024.25.2.699.
2
Pre-CCRT 18-fluorodeoxyglucose PET-CT improves survival in patients with advanced stages p16-negative oropharyngeal squamous cell carcinoma via accurate radiation treatment planning.Pre-CCRT 18-氟脱氧葡萄糖 PET-CT 通过准确的放疗计划改善 p16 阴性局部晚期口咽鳞癌患者的生存。
J Otolaryngol Head Neck Surg. 2023 Feb 13;52(1):14. doi: 10.1186/s40463-023-00623-y.
3
Clinical characteristics and outcomes of cervical lymph node metastasis from unknown primary sites: a single institution's 14-year experience.
原发灶不明的颈部淋巴结转移的临床特征和预后:单中心 14 年经验。
Eur J Med Res. 2023 Jan 3;28(1):5. doi: 10.1186/s40001-022-00957-9.
4
Clinical utility of [Ga]Ga-labeled fibroblast activation protein inhibitor (FAPI) positron emission tomography/computed tomography for primary staging and recurrence detection in nasopharyngeal carcinoma.镓[68Ga]标记成纤维细胞激活蛋白抑制剂(FAPI)正电子发射断层扫描/计算机断层扫描在鼻咽癌原发分期和复发检测中的临床应用。
Eur J Nucl Med Mol Imaging. 2021 Oct;48(11):3606-3617. doi: 10.1007/s00259-021-05336-w. Epub 2021 Apr 1.
5
The Incidence of Nonmalignant Diseases among Patients with Suspected Carcinoma of Unknown Primary Site.原发部位不明的疑似癌症患者中非恶性疾病的发病率。
Intern Med. 2019 May 15;58(10):1423-1428. doi: 10.2169/internalmedicine.1118-18. Epub 2019 Feb 1.
6
A critical appraisal of the quality of head and neck cancer imaging guidelines using the AGREE II tool: A EuroAIM initiative.应用 AGREE II 工具对头颈部癌症影像学指南质量的批判性评价:EuroAIM 倡议。
Cancer Med. 2019 Jan;8(1):209-215. doi: 10.1002/cam4.1933. Epub 2018 Dec 21.
7
Combination of panendoscopy and positron emission tomography/computed tomography increases detection of unknown primary head and neck carcinoma.全内镜检查与正电子发射断层扫描/计算机断层扫描相结合可提高未知原发头颈癌的检出率。
Laryngoscope. 2018 Nov;128(11):2573-2575. doi: 10.1002/lary.27268. Epub 2018 Sep 8.
8
Management delays in patients with squamous cell cancer of neck node(s) and unknown primary site: a retrospective cohort study.颈部淋巴结和不明原发灶鳞状细胞癌患者的治疗延误:一项回顾性队列研究。
J Otolaryngol Head Neck Surg. 2017 May 8;46(1):39. doi: 10.1186/s40463-017-0217-z.
9
[PET-CT in head and neck cancer].[头颈部癌症的正电子发射断层显像-计算机断层扫描(PET-CT)]
HNO. 2017 Jun;65(6):504-513. doi: 10.1007/s00106-017-0355-7.
10
Impact on Patient Management of [18F]-Fluorodeoxyglucose-Positron Emission Tomography (PET) Used for Cancer Diagnosis: Analysis of Data From the National Oncologic PET Registry.[18F] - 氟脱氧葡萄糖 - 正电子发射断层扫描(PET)用于癌症诊断对患者管理的影响:来自国家肿瘤PET登记处的数据分析
Oncologist. 2016 Sep;21(9):1079-84. doi: 10.1634/theoncologist.2015-0364. Epub 2016 Jul 8.